RFL
Rafael Holdings Class B
Stock NYSE – Stock Market Prices, News & Analysis
Rafael Holdings Inc develops and invests in biotechnology and medical companies, particularly in the field of oncology.
Rafael Holdings Class B
RFL
Rafael Holdings Inc develops and invests in biotechnology and medical companies, particularly in the field of oncology.
Price history of Rafael Holdings Class B
Price history of Rafael Holdings Class B
Performance & Momentum
Strategic Analysis
Rafael Holdings Class B • 2026
Rafael Holdings Inc positions itself as a specialist investor in oncology biotechnology companies in the United States, banking on innovative medical breakthroughs in a sector with strong growth potential but high volatility. Its model is based on identifying and financing biopharmaceutical projects in the development stage, representing a risky yet strategic niche within healthcare.
- Strong specialization in oncology, a field driven by medical research and unmet needs.
- Geographic positioning in the United States, a major hub for biotech innovation and healthcare investment.
- Diversified investment model across several development-stage companies, allowing leverage to clinical successes.
- Historically very weak performance, reflecting the uncertain and speculative nature of the projects supported.
- Apparent lack of recent news flow, which may indicate a period of stagnation or reduced visibility for investors.
Current momentum remains weak despite a slight recent rebound; the long-term trend remains bearish, underscoring the risky and speculative nature of the investment. The absence of news catalysts and persistent negative performance call for caution, making this stock suitable only for patient investors with a high tolerance for risk.
Similar stocks to Rafael Holdings Class B
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
